RSV vaccines score landmark FDA approvals

Nat Rev Drug Discov. 2023 Jul;22(7):523-525. doi: 10.1038/d41573-023-00085-x.
No abstract available

Publication types

  • News

MeSH terms

  • Drug Approval
  • Humans
  • Respiratory Syncytial Virus Vaccines*
  • United States
  • United States Food and Drug Administration

Substances

  • Respiratory Syncytial Virus Vaccines